Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
Open Access
- 1 December 2019
- journal article
- research article
- Published by Elsevier in The Lancet Global Health
- Vol. 7 (12) , e1664-e1674
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccinationVaccine, 2013
- Global burden of childhood pneumonia and diarrhoeaThe Lancet, 2013
- Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030Vaccine, 2012
- 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Decline in Rotavirus Hospitalizations and Health Care Visits for Childhood Diarrhea Following Rotavirus Vaccination in El SalvadorThe Pediatric Infectious Disease Journal, 2011
- Health and economic impact of rotavirus vaccination in GAVI-eligible countriesBMC Public Health, 2010
- Rotavirus Vaccination: Cost‐Effectiveness and Impact on Child Mortality in Developing CountriesThe Journal of Infectious Diseases, 2009
- Health Care Costs of Diarrheal Disease and Estimates of the Cost‐Effectiveness of Rotavirus Vaccination in VietnamThe Journal of Infectious Diseases, 2005
- Incidence of Severe Rotavirus Diarrhea in New Delhi, India, and G and P Types of the Infecting Rotavirus StrainsThe Journal of Infectious Diseases, 2005
- Global Illness and Deaths Caused by Rotavirus Disease in ChildrenEmerging Infectious Diseases, 2003